Cytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells.
暂无分享,去创建一个
A. Aigner | F. Czubayko | S. Abuharbeid | M. Zuzarte | M. Langer | J. Apel | Martin Sander | Babette Fiedler | Shaker Abuharbeid | Marylou Zuzarte